• Profile
Close

Impact of intestinal mannitol on hyperammonemia, oxidative stress and severity of hepatic encephalopathy in the ED

The American Journal of Emergency Medicine Jan 13, 2018

Montes-Cortés DH, et al. - In patients with chronic liver disease (CLD), researchers evaluate if intestinal mannitol is as effective and safe as conventional treatment for diminishing hyperammonemia, oxidative stress, and hepatic encephalopathy. Intestinal mannitol proved to have comparable efficacy and safety profile as conventional treatment for reducing hyperammonemia, oxidative stress, and hepatic encephalopathy of CLD patients in the emergency room. Besides, mannitol is better tolerated than conventional treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay